tirzepatide for chronic pain Week 3 update of taking (GLP-1) my & chronic inflammation with suspicions of diaphragmatic endometriosis (already diagnosed with Lyme disease, thoracic outlet syndrome & Endometriosis & Ozempic, What's the
Description
Ozempic side effects like nausea, diarrhea, and vomiting can lead to dehydration
Qu Liu C th gp cc triu chng nh bun nn, nn ma, tiu chy, au bng, v tt ng huyt
W., & the SELECT Trial Investigators
The approved NHS pathways are: Wegovy (semaglutide) licensed for weight management via NICE TA875 (BMI 35+ with one condition, via tier 3 services) and NICE cardiovascular guidance April 2026 (BMI 27+ with established CVD, via GP) Mounjaro (tirzepatide) licensed for weight management via NICE TA1026 (BMI 35+ with four conditions from June 2026, via tier 3 or QOF GP pathway) Ozempic (semaglutide) NOT approved for NHS weight management
Youd follow a similar process in reverse, including a one-week gap, and then start at an appropriate Wegovy dose
